Connect with us

Press Release

ADAMoracle—The First Decentralized Oracle That Supports Wide-area Node Quotation

Published

5 years ago

on

The birth of ADAMoracle

In the blockchain system, there are underlying service providers that provide vital nutrition to the main system, but are not easily noticed by the public, which is oracle. As a middleware connecting the blockchain system and real-world data, the oracle is a bridge that connects outside data with blockchain world and realizes the exchange of data and information .

With the large-scale application of blockchain technology in recent years, DeFi, NFT and other fields have shown a blowout development, and the market’s demand and requirements for underlying services are also constantly improving. However, the current major oracle products are still largely opaque, inaccurate, difficult to expand, and poorly resistant to attacks. Oracles that can truly meet market demand in an all-round way are extremely scarce.

Our Background Advantage

In order to meet the growing demand of the market, in July 2020, the ADAMoracle laboratory was officially established in the Emirate of Dubai, led by Ahmed Ebrahim, the founder and CEO of ADAMoracle, and the team led by CMO Christopher Quet and COO Olga Petrovska set out to create brilliant oracle products .

ADAMoracle has been favored by a large number of capital and institutions at the beginning of the establishment of the project. So far, ADAMoracle has obtained Collinstar, Redline Capital, CoinBene Labs, BTXCapital, 7O’Clock Foundation, MCS Capital, ChainUP Capital, ZB Labs ,Chain Capital and other dozens of institutions have strategic investment of USD 2 million.

ADAMoracle builds Web3.0 distributed wide-area node computing oracle network

In the Web3.0 blockchain network era, a complete middle-tier infrastructure will promote the next stage of the growth engine of the blockchain. However, the performance of the oracle network currently on the market and the cumbersomeness of building applications have discouraged many DeFi DApps. ADAMoracle is committed to changing the current status quo and completing a truly decentralized oracle network.

Web 3.0 developers can use ADAMoracle to implement a decentralized computing network with cross-chain support for multi-node computing. For the DeFi application market, customers connect to ADAMoracle through smart contracts to obtain prices, and obtain more accurate and secure quotations through multi-node connection quotations. At the same time, data is automatically distributed and stored. Each price feed will better verify the degree of decentralization, data accuracy, stronger stability and safety, and scalability of ADAMoracle.

Major features of ADAMoracle system

High security: ADAMoracle avoids a single point of failure by connecting multiple nodes to calculate and verify the quotation; the both way quotation and price verification prevent ADAMoracle from related attacks and further losses to customers;

Decentralization (high participation): ADAMoracle can connect to multiple types of servers through the global node to become bidders and verifiers, and participate in the oracle price generation. Many members can participate in the future development route of ADAMoracle;

High scalability: ADAMoracle supports more cross-chain DeFi DApps applications based on Polkadot, OKExChain, and BSC, compatible with many blockchain technology development frameworks, and builds a Defi application ecosystem in a friendly collaboration with developers;

High accuracy: with an oracle performance evaluation system, the deviation between the quotation per minute and the market price is accurate to 0.0012, it is very accuracy quotation system.

Low threshold: ADAMoracle can be connected to multiple types of servers, which greatly reduces maintenance and operation costs and achieves a quotation system platform that everyone can participate in.

The operation flow of ADAMoracle is as shown in the figure above. Customer release request–ADAMOracle Saas System releases the request contract after receiving it–System picking up nodes–Wide area node quotation–Aggregation of data provided by wide area node data providers–receving accurate Results–feedback to customers.

This process includes the three roles of data aggregator, node computing provider, and storage service provider in the ADAMoracle operation flow.

ADAMoracle data aggregator:

Data aggregators obtain key data from multiple exchanges (for example: OKEx, Coinbase, Huobi, Binance, etc.), and transmit the most reliable data to the ecosystem, thereby providing safe and reliable prices for the DeFi protocol Data, truly realize the decentralization of ADAMoracle data source and ensure the openness and transparency of data;

Node Computing provider:

As the first decentralized oracle that supports wide-area node quotation, the data service on the ADAMoracle chain has the advantage of high security and low threshold. The ADAMoracle has created a grand node service network, which can accommodate thousands of service providers for data verification and quotation services at the same time, which not only ensures the accuracy and credibility of the data, but also improves the anti-attack of the oracle itself. Lower the threshold for participation. Any enterprise or individual that has certain basic server equipment, has certain technical operation and maintenance capabilities, and can start nodes to complete Docker images, can join the ADAMoracle ecosystem and share the token ADAM dividend.

ADAMoracle has 33 global nodes and 66 backup nodes worldwide, and the global node can create its own mining pool in the future to connect thousands of multiple types of servers for secure distributed quotation, and the distributed quotation system is effective, This avoids the occurrence of a single point of failure, and provides a safer and more reliable quotation service for corporate customers.

Storage Service Provider

ADAMoracle not only implements a wide-area distributed quotation system under the multi-node computing network, but also securely distributes the generated on-chain/off-chain data to the blockchain storage system to prevent data loss. The decentralized oracle network is committed to the fact that every mining machine can become a offerer and verifier, participate in the oracle price quotation, and jointly govern and decide the future development route of ADAMoracle.

Summary:The ADAMoracle wide-area node computing network oracle architecture realizes unbounded interstellar network computing, so that each multi-type server can realize automated quotation, and has a safe rating function to ensure the accuracy of the price and better guarantee the oracle. The network’s decentralization characteristics and availability performance make it possible to have both fish and bear’s paws. ADAMoracle will attract more excellent developers to create excellent DeFi DApps applications. These new business paradigms of Web3.0 will also become a new form of economic society and organization in the future.

Our Economic Advantages

ADAMoracle for sustainable long-term development

Different from Bitcoin, ADAMoracle is not only a “green project” with decentralized energy resources, but also an infrastructure service facility that serves the majority of DeFi ecological projects. That is to say, the value of the ADAMoracle is not limited to the consensus of its own users. It will also generate actual value as the industry grows and develops. In the future, the ADAMoracle will support OKExchain, ETH, BSC, HECO, Polkadot and other public chains to further expand the ecology and promote the development of rich business formats such as lending, asset synthesis, and prediction markets.

ADAMoracle is a project that seeks long-term and stable development. It is based on the DeFi ecosystem, focuses on the entire blockchain system, and focuses on providing smart contract developers with comprehensive tools and data. ADAM is ADAMoracle’s contribution reward token to participants. It is the core value of the ecosystem. Its value comes from the value contribution of ecological members. The total issuance of ADAM is 100 million.

There are several ways to obtain ADAM tokens:

1. Participate in mining to obtain

50% of ADAM tokens are produced by mining, which is one of the main ways to obtain ADAM. Users can obtain ADAM token rewards by participating in pledge or liquidity mining;

2. Participate the ADAMoracle architecture

At present, the ADAMoracle has officially started the recruitment of global nodes, and many storage nodes will be recruited in the future. As a member of the ADAMoracle ecosystem, you can not only share the ADAMoracle development dividends, but also share the handling fees paid by the data demander. Currently, many Dapp projects have rigid data requirements. When they issue data requests to the ADAMoracle oracle machine, they need to pay ADAM as a handling fee. The node computing provider can obtain the corresponding ADAM by providing accurate quotation for the data demander; Aggregators and storage service providers can also get a corresponding share.

3.Participate to build up ADAMoracle ecological

ADAMoracle is a project that adopts decentralized community voting governance. The higher the value contribution of ecological members, the more ADAM token incentives will be obtained.

In the future, we will also establish “ADAMoracle Labs”, aiming to establish an open decentralized financial ecosystem based on the oracle protocol, and use the advantages of encrypted economic incentives to obtain and verify data. Allow the majority of ecological participants to better participate in our ecological construction, expand ecological application scenarios, form an ecological closed loop, and share and use financial digital asset data.

In general, the ADAMoracle creates a continuous positive incentive. The more users there are, the more fees will be generated; the more ecological participants, the higher the value of ADAM itself. At the same time, the increase in the value of ADAM is more conducive to the adoption of ADAMoracle oracles. Like Bitcoin, miners will compete to dig blocks for Token rewards to form a virtuous circle.

Looking around at the current high-quality oracle projects in the market, there are not a few that have a market value of over 100 million US dollars. Behind the prosperity that the total market value of cryptocurrencies exceeded US$2.5 trillion, there are countless groups who have quietly dedicated themselves to them. They do not take the model hotspot as a paradigm, but are rooted in the most basic field of the industry and empower the industry to flourish. They will never Forgotten by people.

About Author

Alex Jacob

Alex Jacob is a literature author. He was born in Chicago. Alex passion is writing news articles. He writes number of articles and published it.

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

Published

13 hours ago

on

December 11, 2025

By

SHENZHEN, CHINA – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke.

 

With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important targets PSD95-nNOS and MPO, in the pathological processes of stroke, Y-3 for Injection acts on multiple key pathological processes of the ischemic cascade in ischemic stroke. Through multi-target, highly selective synergy, it is more conducive to exerting brain cytoprotective effects. The Product has an excellent therapeutic effect on ischemic stroke and the potential to prevent post-stroke depression and anxiety symptoms.

 

Y-3 for Injection demonstrates excellent clinical data with excellent efficacy and a favorable safety profile. The results of Phase II clinical trial of the Product in China indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (40mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group, with a rate difference of 16%. The Phase III clinical trial of the Product in China was conducted by Beijing Tiantan Hospital, Capital Medical University as the leading site. It has enrolled nearly 1,000 patients with acute ischemic stroke within 48 hours of onset across approximately 40 research centers nationwide, aiming to evaluate the efficacy and safety of Y-3 for Injection in treating patients with acute ischemic stroke within 48 hours of onset. The Phase III clinical study met the primary efficacy endpoint, with patients achieving significant clinical benefits and an overall favorable safety profile. The key study results are planned to be presented at international academic conferences, and the full study will be published in international academic journals.

 

The Central Nervous System (CNS) is one of the core advantageous fields of CMS, where a deeply integrated layout has been progressively established. The product portfolio has solidified the market foundation, including the marketed innovative drug VALTOCO (Diazepam Nasal Spray), the original brand drug Deanxit (Flupentixol and Melitracen Tablets), and the improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets), which is currently under NDA review. The addition of Y-3 for Injection will further strengthen the product portfolio, generating highly efficient synergies in terms of expert networks and market resources. It is expected that if approved for marketing, Y-3 for Injection will bring a new generation of brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects to Chinese patients with ischemic stroke. Leveraging the successful commercialization experience and compliant and efficient operation system, the Group will accelerate the accessibility of innovative therapies to benefit more patients.

 

More Information about Y-3 for Injection

The pathological processes of acute ischemic stroke are highly complex and interconnected. There is an urgent clinical need for multi-target, multi-mechanism coordinated interventions to achieve more effective regulation of the complex ischemic cascade, thereby improving treatment outcomes and enhancing patients’ quality of life. Y-3 for Injection is able to uncouple PSD95-nNOS, inhibit MPO activity, and enhance the activity of α2-GABAA receptor (a subtype of GABAA receptor with antidepressant and anxiolytic effects). With this multi-target, highly selective synergistic mechanism, it is expected to achieve a technological breakthrough in the simultaneous intervention of “stroke treatment and prevention of post-stroke depression and anxiety”, making Y-3 for Injection a promising novel brain cytoprotectant with excellent efficacy and more comprehensive therapeutic effects.

 

The results of Phase II clinical trial of Y-3 for Injection for the treatment of acute ischemic stroke were presented as an oral poster at the 10th European Stroke Organisation Conference in 2024 (ESOC 2024). It indicated that among patients with ischemic stroke within 48 hours of onset, patients in the Y-3 group (20mg, 40mg, 60mg, qd) demonstrated a significantly higher proportion of patients achieving an excellent functional outcome (mRS of 0-1) at 90 days than those in the placebo group (20mg: 67.8% vs 60.7%, 40mg: 76.7% vs 60.7%, 60mg: 70.0% vs 60.7%). Moreover, the Product showed comparable safety to placebo in acute ischemic stroke patients, exhibiting good tolerability.

 

On 24 August 2023, the Group through its wholly-owned subsidiary entered into a Collaboration Agreement (the “Agreement”) with Neurodawn Pharmaceutical Co., Ltd. (“NeuroDawn”), a clinical needs-oriented pharmaceutical company driven by innovation and R&D. In accordance with the Agreement, the Group obtains an exclusive promotion right in mainland China, the Hong Kong Special Administrative Region, and the Macau Special Administrative Region. The term of the Agreement is permanent.

 

About Stroke

According to the Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) issued by the National Health Commission, approximately 3.94 million new stroke cases occur in China each year, accounting for one-third of the global new cases[1]. Among these, ischemic stroke accounts for about 72%, with over 2.8 million new cases annually; the number of existing stroke patients in China has exceeded 28 million[1]. Data from China’s cause-of-death monitoring in 2021 shows that stroke-related deaths accounted for 23% of the national total deaths[1]. Over the past three decades, the disease burden of stroke-related disabilities in China has continued to increase[1]. Coupled with factors such as the accelerating aging of the population, the pressure of stroke prevention and control will further intensify in the future, posing enormous challenges to patients’ families and society[1]. In addition, post-stroke depression and anxiety are common complications of stroke, with incidence rates of approximately 30% and 25% respectively[2]. They can hinder the recovery of patients’ neurological functions, even increase the risk of death, and severely affect patients’ prognosis. Y-3 for Injection holds significant potential value for the long-term neurological function improvement and overall prognosis of a vast number of stroke patients, indicating broad market prospects.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

Reference

  1. National Health Commission of the People’s Republic of China. Guideline for Prevention and Treatment of Cerebrovascular Disease (2024 Edition) [J]. Chinese Journal of Magnetic Resonance Imaging, 2025, 16(1): 1-8. DOI: 10.12015/issn.1674-8034.2025.01.001.
  2. Chen Xinyu, Lyu Xiaohan, Li Ruina, et al. Post-Stroke Anxiety [J]. International Journal of Cerebrovascular Disease, 2022, 30(2): 129-133. DOI: 10.3760/cma.j.issn.1673-4165.2022.02.010.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

 

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Kevin Wall of Worcester Encourages Greater Civic Engagement Around Civil Liberties

Published

14 hours ago

on

December 11, 2025

By

Worcester, Massachusetts, 11 Dec 2025, ZEX PR WIRE, As debates over privacy, free speech, and policing continue to unfold nationwide, local residents like Kevin Wall of Worcester are encouraging more community awareness around civil liberties and individual rights.

Wall, who has lived in Worcester for over a decade, says many people care about these issues but don’t always know where to start. “Most people I talk to want things to be fair and transparent,” Kevin Wall said. “They’re concerned about surveillance, about how schools handle discipline, about what kind of data companies and the government collect. But they don’t always feel equipped to speak up.”

Though not affiliated with any organization, Wall often shares resources from civil rights groups like the ACLU, especially those related to Massachusetts policies and digital rights. He follows court decisions and legislative changes and encourages others to do the same. “You don’t have to be an expert. Just being informed helps you spot when something isn’t right.”

In Massachusetts, recent civil liberties conversations have included facial recognition technology bans, school-based surveillance tools, bail reform, and expanded voting access. Organizations like the ACLU of Massachusetts have weighed in on many of these issues, publishing legal analysis and policy recommendations.

Worcester itself has seen growing interest in these topics. In recent years, the city has hosted forums on data privacy, transparency in school policies, and police oversight. Wall sees this as a sign of a more engaged public. “It’s not about being political,” he said. “It’s about understanding how systems work and making sure people are treated fairly.”

He says the rise of AI and digital tracking tools has made the public role more important than ever. “The tools are changing fast. You need people who are paying attention and asking questions.”

Wall is particularly focused on issues that affect everyday life: student discipline policies, use of technology in public spaces, and due process protections in local courts. “You can’t protect your rights if you don’t know what they are,” he said. “Groups like the ACLU do a good job breaking it down.”

For Worcester residents looking to get more involved, Wall recommends starting small. “Read a case summary. Sign up for an email list. Go to a local meeting. Even asking questions at a school board or city council meeting makes a difference.”

While he doesn’t speak publicly or run a group, Wall believes that quiet civic engagement still matters. “There are lots of ways to contribute without being front and center.”

He hopes more residents in Worcester will take interest in how rights are shaped and protected at the local level. “We all benefit when more people pay attention. Whether it’s about speech, privacy, education, or equal treatment, these issues affect all of us.”

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Kevin Wall Worcester: Local Voices Add Perspective as Civil Liberties Take Center Stage

Published

14 hours ago

on

December 11, 2025

By

Worcester, Massachusetts, 11 Dec 2025, ZEX PR WIRE, From school board meetings to courtroom challenges, the conversation around civil liberties in America is evolving. In cities like Worcester, residents such as Kevin Wall are quietly helping keep those conversations alive.

Wall isn’t a politician or spokesperson. He’s a longtime Worcester resident who takes an active interest in civil rights and regularly shares articles and legal updates with friends and neighbors. He says staying informed is part of being a responsible member of the community. “It’s not about having all the answers,” he said. “It’s about knowing enough to ask the right questions.”

Across the country, major civil liberties issues are in the spotlight—digital surveillance, student speech, reproductive rights, and access to public records among them. The ACLU and other legal groups continue to play a key role in shaping public understanding and defending constitutional protections.

Wall keeps tabs on this work, particularly from the ACLU of Massachusetts. “They’re one of the groups that actually explains things in plain language,” he said. “I follow their email briefings and court updates.”

In Worcester, topics like facial recognition, police transparency, and equity in school discipline have generated local interest. Wall believes these conversations are healthier when more people feel empowered to participate. “When you understand your rights, you’re more likely to speak up,” he said. “And when regular people speak up, public systems tend to work better.”

Although Wall doesn’t attend public events or speak on panels, his role is more grassroots. He brings up civil liberties topics in everyday conversation and encourages others to learn more. “People are surprised by how much these things touch their lives—how a policy might affect their kid at school or the way local police handle data.”

He’s especially concerned about how fast technology is changing the landscape. “AI tools, data collection, automated decisions—these are things that need public oversight,” Wall said. “You don’t need to be paranoid, but you should know what’s happening.”

Wall represents a growing number of residents who take an interest in public life without making it their job. “Not everyone wants to go to rallies or run for office,” he said. “But that doesn’t mean they don’t care. Being informed is a kind of participation.”

The ACLU continues to advocate for strong protections around voting access, LGBTQ+ rights, free expression, and immigration policy—many of which have direct implications for Worcester residents. Wall believes that raising awareness is a shared responsibility. “Organizations can only do so much. People need to take that extra step—read more, talk more, think more critically.”

As legal and political battles continue across the country, local voices like Kevin Wall’s reflect a broader truth: civil liberties aren’t just an issue for lawyers and lawmakers. They belong to everyone. And in Worcester, more residents are starting to take notice.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us